NCT06709742

Brief Summary

Cerebral Palsy (CP) is a infancy and early childhood disorder that results in motor impairment caused by static and non-progressive lesions in the brain. It has an impact on both the neurological and musculoskeletal systems of the bod. According to the Cerebral Palsy Alliance Research Foundation (CPARF) \& WHO Cerebral Palsy Statistics 2023, approximately 17 million individuals experience some form of CP. This data underscores a notable prevalence rate of 1.5 cases per 1,000 live births within the High-Income Countries (HICs), limited but growing data are obtained from both the Lower Middle-Income Countries (LMICs. The incidence of CP among children in the Swabi district of Khyber Pakhtunkhwa, Pakistan, was 1.22 per 1000 live births. The overall prevalence in Pakistan is still not known, but according to recent documentation, it is estimated to be 4 out of every 1000 live births. The symptoms in CP encompassing atypical muscle contractions, alteration in posture and limitations in movement and physical activity. Furthermore,these symptoms are accompanied by disruptions in sensory perception and cognitive processing along with the challenges of communication, behavioral issues, epileptic seizures and secondary musculoskeletal complications. Motor deficit is present in 65.56% percent of CP cases as well as balance is impaired in most of the cases, and different impairments combinedly decreased overall quality of life (QOL). Because activities of daily living are decreased which in a result increases the caregiver's workload.Despite such a high prevalence of CP, there is still no standardized treatment approach implemented in the clinical settings due to their individualized needs and varying degrees of impairment. Consequently, our study seeks to address this gap by investigating the effect of Goal-Oriented individualized GMFM based programs on enhancing gross motor function, balance and quality of life. By elucidating the potential benefits of intervention, our study aims to contribute to the optimization of therapeutic approaches tailored to the different needs of children with CP.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 15, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 18, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 29, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

November 29, 2024

Status Verified

September 1, 2024

Enrollment Period

6 months

First QC Date

November 18, 2024

Last Update Submit

November 25, 2024

Conditions

Keywords

Cerebral PalsyGross motor functionBalanceQuality of LifeCPGMFM-88BESTestCP QOL

Outcome Measures

Primary Outcomes (9)

  • Gross Motor Function

    The GMFM-88 (Gross Motor Function Measure-88) is a scale used to assess gross motor function in children with CP.

    At Baseline

  • Gross Motor Function

    The GMFM-88 (Gross Motor Function Measure-88) is a scale used to assess gross motor function in children with CP.

    Through study completion, at 16th week

  • Gross Motor Function

    The GMFM-88 (Gross Motor Function Measure-88) is a scale used to assess gross motor function in children with CP.

    followup of 2 weeks.

  • Balance

    The Kids BESTest Scale (Balance Evaluation Systems Test) is used to assess balance in children with CP.

    At Baseline

  • Balance

    The Kids BESTest Scale (Balance Evaluation Systems Test) is used to assess balance in children with CP.

    Through study completion, at 16th week

  • Balance

    The Kids BESTest Scale (Balance Evaluation Systems Test) is used to assess balance in children with CP.

    followup of 2 weeks.

  • Quality Of Life

    The CP QOL (Cerebral Palsy Quality of Life) questionnaire is used to assess the quality of life in children with CP.

    At Baseline

  • Quality Of Life

    The CP QOL (Cerebral Palsy Quality of Life) questionnaire is used to assess the quality of life in children with CP.

    Through study completion, at 16th week

  • Quality Of Life

    The CP QOL (Cerebral Palsy Quality of Life) questionnaire is used to assess the quality of life in children with CP.

    followup of 2 weeks.

Study Arms (1)

Intervention Group

EXPERIMENTAL

The Intervention based on GMFM-88 items will be given 3 times per week for a duration of 40-45 minutes for each session for 16 weeks.

Other: Gross Motor Function Measure-88 Based Therapy

Interventions

Children will be assessed initially by using GMFM-88 and selecting specific items for individuals according to his/her needs with the help of experts and family. At least 3 items will be selected for each subject in which they score less such that 0, 1 or 2. Training based on those specific items will be given to the children. This is goal-oriented training in which, according to the needs of children training will be provided.

Also known as: GMFM-88 Based Therapy
Intervention Group

Eligibility Criteria

Age5 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosed Cerebral Palsy,
  • Age 5-16 years,
  • GMFCS Level I, II \& III,
  • Able to understand instructions,
  • With/ without any assistive devices.

You may not qualify if:

  • CP children with any respiratory disorders,
  • Undergoing surgery within the past 6 months,
  • Botulinum injection within the last 6 months,
  • Unstable seizures,
  • Co-existing condition (ADHD, Metabolic Disorder, Progressive disorder),
  • Any other co-morbid causing difficulty in performing tasks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

ACELP Institute of Child Development

Karachi, Sindh, 07553, Pakistan

Location

Dar-ul-Sukun

Karachi, Sindh, 74200, Pakistan

Location

Related Publications (5)

  • Lee M, Ko Y, Shin MM, Lee W. The effects of progressive functional training on lower limb muscle architecture and motor function in children with spastic cerebral palsy. J Phys Ther Sci. 2015 May;27(5):1581-4. doi: 10.1589/jpts.27.1581. Epub 2015 May 26.

    PMID: 26157267BACKGROUND
  • Paul S, Nahar A, Bhagawati M, Kunwar AJ. A Review on Recent Advances of Cerebral Palsy. Oxid Med Cell Longev. 2022 Jul 30;2022:2622310. doi: 10.1155/2022/2622310. eCollection 2022.

    PMID: 35941906BACKGROUND
  • McIntyre S, Goldsmith S, Webb A, Ehlinger V, Hollung SJ, McConnell K, Arnaud C, Smithers-Sheedy H, Oskoui M, Khandaker G, Himmelmann K; Global CP Prevalence Group*. Global prevalence of cerebral palsy: A systematic analysis. Dev Med Child Neurol. 2022 Dec;64(12):1494-1506. doi: 10.1111/dmcn.15346. Epub 2022 Aug 11.

    PMID: 35952356BACKGROUND
  • Cooper MS, Fahey MC, Mackay MT. Making waves: The changing tide of cerebral palsy. J Paediatr Child Health. 2022 Nov;58(11):1929-1934. doi: 10.1111/jpc.16186. Epub 2022 Sep 6.

    PMID: 36066306BACKGROUND
  • Abd-Elfattah HM, Ameen FH, Elkalla RA, Aly SM, Abd-Elrahman NAF. Loaded Functional Strength Training versus Traditional Physical Therapy on Hip and Knee Extensors Strength and Function Walking Capacity in Children with Hemiplegic Cerebral Palsy: Randomized Comparative Study. Children (Basel). 2022 Jun 24;9(7):946. doi: 10.3390/children9070946.

    PMID: 35883930BACKGROUND

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Dr.Amna Aamir Khan, PhD

    Ziauddin College of Physical Therapy, Ziauddin University

    STUDY DIRECTOR
  • Ifra Neelum, MPhil

    Ziauddin College of Physical Therapy, Ziauddin University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

November 18, 2024

First Posted

November 29, 2024

Study Start

August 15, 2024

Primary Completion

February 1, 2025

Study Completion

March 1, 2025

Last Updated

November 29, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations